Latest Videos |view all videos
Clinical CAR T-cell Trial for Multiple Myeloma Suggests Possible “Cure”
For the first time, patients on a new CAR T-cell therapy for multiple myeloma are experiencing remission long enough to be cautious deemed cured of their disease.
Exploring HIPEC Treatment as an Option for Peritoneal Cancers
HIPEC is part of a two-step process for cancers that either originate in the peritoneal cavity or migrate there from an organ.
Roswell Park Adopts New Robotic Bronchoscopy System for More Accurate Biopsies
Roswell Park is utilizing a new tool, the Galaxy robotic bronchoscope system, for more accurate lung nodule imaging and biopsies.
Cellular Therapies Leading to New Treatment Options for Lymphoma Patients
A new CAR T-cell consortium, Matthew Cortese, MD, MPH, a hematologic oncologist at Roswell Park Comprehensive Cancer Center, shares that certain types of hard-to-treat lymphomas may be more receptive to immunotherapies than previously thought.
Meet the Team: Ankit Patel, MD
The newest member of Roswell Park Comprehensive Cancer Center’s melanoma and sarcoma team considers his appointment a homecoming.
New Immunotherapy Trials Offer Hope to Previously Excluded Gynecologic Cancer Patients
Roswell Park Comprehensive Cancer Center offers gynecologic cancer patients multidisciplinary care from nationally recognized specialists who collaborate on personalized treatment plans.
Early Detection and Symptom Recognition Key for Young Adult Colorectal Cancer Patients
Rates of colorectal cancer are on the rise among young adults, a trend that continues to puzzle oncologists
“Nuance” is Important When Discussing Hormone Replacement Therapy
The use of hormone replacement therapy for women has become a controversial topic since the publication of the Women’s Health Initiative study more than 20 years ago
Roswell Park Set to Open Several New Trials this Year for Innovative CAR T-Cell Therapies
CAR T-cell therapies are the future of cancer treatment and Roswell Park Comprehensive Cancer Center is preparing to open a number of new trials based on research originating here and in partnership with the industry.